期刊文献+

不同保存介质对脐带间充质干细胞活性的影响 被引量:1

Effects of different storage solutions on the viability of umbilical cord mesenchymal stem cells
下载PDF
导出
摘要 背景:脐带间充质干细胞的临床应用面临移植前保存的问题,而临床保存介质对移植前细胞活性的影响直接关乎移植后疗效,目前却缺乏对临床介质保存效果的系统性研究。目的:评价临床常用保存介质对脐带间充质干细胞活性的影响。方法:在4℃与室温(25℃)条件下,将脐带间充质干细胞在临床常用保存液(0.9%氯化钠注射液,5%葡萄糖注射液和1%人血白蛋白溶液)中保存2,4,6 h,观察上述保存介质对脐带间充质干细胞活性、凋亡/死亡率、多向分化能力及DNA损伤的影响。结果与结论:无论在4℃还是室温条件下,细胞在临床常用保存介质中的活性均在短期内呈时间依赖性下降。此外,不同保存介质引起细胞死亡而非凋亡,且死亡率呈时间依赖性增加;经不同介质保存后,细胞出现DNA损伤,但其增殖与多向分化能力未受明显影响,提示细胞核DNA损伤为细胞活性下降的关键因素。 BACKGROUND: Umbilical cord-mesenchymal stem cells (UC-MSCs) have been widely studied in clinics. Notably, UC-MSCs have to be properly preserved before clinical use and the effects of storage solution on viability of cells play critical roles in the effectiveness of cell-transplantation. However, there are few studies concerning this phenomenon. OBJECTIVE: To evaluate the effects of various clinical common solutions on the activity of UC-MSCs. METHODS: UC-MSCs were stored at 0,9% sodium chloride injection, 5% glucose injection and 1% human serum albumin respectively at 4 ~C and room temperature (25 ~C) for 2, 4 or 6 hours. Viabilities, apoptosis/necrosis rate multi-differentiation ability of preserved UC-MSCs and DNA damage were examined. RESULTS AND CONCLUSION: The viabilities of UC-MSCs were rapidly decreased time-dependently in all of the storage solutions both at 4 ~C and room temperature. Besides, the storage solutions resulted in cellular necrosis rather than apoptosis and the necrosis rate was greatly increased time-dependently. DNA damage was observed in cells after preserved in various storage solutions, but cell proliferation and differentiation were not affected, which demonstrated that DNA damage may be a key factor for the reduction of cell viabilities.
出处 《中国组织工程研究》 CAS CSCD 2014年第14期2153-2160,共8页 Chinese Journal of Tissue Engineering Research
关键词 脐带间充质干细胞 临床保存 细胞活性 介质 细胞核DNA损伤 临床应用 时间依赖性 氯化钠注射液 stem cells mesenchymal stem cells umbilical cord stem cell transplantation preservation,biological
  • 相关文献

参考文献31

  • 1Eggenhofer E, Steinmann JF, Renner P, et al. Mesenchymalstem cells together with mycophenolate mofetil inhibit antigenpresenting cell and T cell infiltration into allogeneic heartgrafts.Transplant Immunol.2011;24(3):157-163.
  • 2Li Lin, Tian Hui, Yue Weiming, et al. Human mesenchymalstem cells play a dual role on tumor cell growth in vitro and invivo. J Cell Physiol.2011;226(7):1860-1867.
  • 3Wu KH, Chan CK, Tsai C, et al. Effective treatment of severesteroid-resistant acute graft-versus-host disease withumbilical cordderived mesenchymal stem cells.Transplantation. 2011; 91: 1412-1416.
  • 4Chen A, Siow B, Blamire AM,et al.Transplantation ofmagnetically labeled mesenchymal stem cells in a model ofperinatal brain injury. Stem Cell Res.2010;5(3):255-266.
  • 5Lim JY, Park SI, Kim SM, et al.Neural differentiation ofbrain-derived neurotrophic factor-expressing human umbilicalcord blood-derived mesenchymal stem cells in culture viaTrkB-mediated ERK and-catenin phosphorylation andfollowing transplantation into the ceveloping brain. CellTransplant.2011;11(12):1855-1866.
  • 6da Silva Meirelles L, Chagastelles PC, et al. Mesenchymalstem cells reside in virtually all post-natal organs and tissues.J Cell Sci.2006; 119(Pt11): 2204-2213.
  • 7Krampera M, Sartoris S, Liotta F, et al. Immune regulation bymesenchymal stem cells derived from adult spleen andthymus. Stem Cells.2007;16(5):797-810.
  • 8Tsai MS, Hwang SM, Chen KD, et al. Functional networkanalysis of the transcriptomes of mesenchymal stem cellsderived from amniotic fluid, amniotic membrane, cord blood,and bone marrow. Stem Cells.2007;25(10):2511-2523.
  • 9Fridenshte?n AIa, Piatetski?-Shapiro II, Petrakova KV.Osteogenesis in transplants of bone marrow cells. Arkh AnatGistol Embriol.1969; 56: 3-11.
  • 10Stolzing A,Jones E,McGonagle D,et al.Age-related changesin human bone marrow-derived mesenchymal stem cells:consequences for cell therapies. Mech Ageing Dev.2008;129(3): 163-173.

二级参考文献33

  • 1卢润章,赵经慧,程梅,王志国,王洪岩,陈立君,马军.人脐带间充质干细胞体外培养的生物学特性研究[J].黑龙江医学,2013,37(2):81-83. 被引量:4
  • 2Lee JW,Fang X,Krasnodembskaya A. Concise review:Mesenchymal stem cel s for acute lung injury:role of paracrine soluble factors[J].Stem Cel s,2011,(06):913-919.
  • 3Semenov OV,Koestenbauer S,Riegel M. Multipotent mesenchymal stem cel s from human placenta:critical parameters for isolation and maintenance of stemness after isolation[J].{H}AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,2010,(02):193e1-193e13.
  • 4Tran CT,Huynh DT,Gargiulo C. In vitro culture of Keratinocytes from human umbilical cord blood mesenchymal stem cel s:the Saigonese culture[J].Cel Tissue Bank,2011,(02):125-133.
  • 5Can A,Balci D. Isolation,culture,and characterization of human umbilical cord stroma-derived mesenchymal stem cel s[J].{H}Methods in Molecular Biology,2011.51-62.
  • 6Singleton PA,Salgia R,Moreno-Vinasco L. CD44 regulates hepatocyte growth factor-mediated vascular integrity.Role of c-Met,Tiam1/Rac1,dynamin 2,and cortactin[J].{H}Journal of Biological Chemistry,2007,(42):30643-30657.
  • 7Mei SH,McCarter SD,Deng Y. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cel s overexpressing angiopoietin 1[J].{H}PLOS MEDICINE,2007,(09):e269.
  • 8Manning E,Pham S,Li S. Interleukin-10 delivery via mesenchymal stem cel s:a novel gene therapy approach to prevent lung ischemia-reperfusion injury[J].{H}Human Gene Therapy,2010,(06):713-727.
  • 9Olson AL,Swigris JJ. Idiopathic pulmonary fibrosis:diagnosis and epidemiology[J].{H}CLINICS IN CHEST MEDICINE,2012,(01):41-50.
  • 10Cho PS,Messina DJ,Hirsh EL. Immunogenicity of umbilical cord tissue derived cel s[J].{H}Blood,2008,(01):430-438.

共引文献6

同被引文献24

  • 1Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from humanadipose tissue implications for cell-based therapies[J]. Tissue Eng,2001,7(2):211-228.
  • 2Lin K, Matsubara Y,Masuda Y, et al. Characterization of adiposetissue-derived cells isolated with the Celution system [J].Cytontherapy, 2008, 10(4):417-426.
  • 3Yoshimura K, Shigeura T, Matsumoto D, et al. Characterization offreshly isolated and cultured cells derived from the fatty and fluidportions of liposuction aspirates[J]. Cell Physiol,2006, 208(1):64-76.
  • 4Miranville A, Heeschen C,Sengenes C, et al. Improvement ofpostnatal neovascularization by human adipose tissue-derived stemcells[J].Circulation,2004,110(3):349-355.
  • 5Zhu M, Zhou Z, Chen Y, et al. Supplementation of fat graftswith adipose-derived regenerative cells improves long-term graftrerention[J]. Ann Plast Surg, 2010, 64(2):222-228.
  • 6Baust JG, Gao D, Baust JM. Cryopreservation: An emergingparadigm change [J]. Organogenesis. 2009; 5(3):90-96.
  • 7Pu LL,Cui X,Fink BF,et al. Adipose aspirates as a source for humanprocessed lipoaspirate cells after optimal cryopreservation [J]. PlastReconstr Surg,2006,117( 6): 1845-1850.
  • 8Polchow B’Kebbel K,Schmiedeknecht G,et al.Cryopreservation ofhuman vascular umbilical cord cells under good manufacturing practiceconditions for future cell banks[J]. Transl Med,2012,10( 1) : 98.
  • 9Guang peng,Liu Yulin, Li Jian, et al. Evaluation of the viability andosteogenic differentiation of cry preserved human adipose-derivedstem cell [J]. Cryobiology, 2008, 57(1):18-24.
  • 10CalvetL, Cabrespine A, Boiret-Dupr, et al.Hematologic,immunologic reconstitution, and outcome of 342 autologousperipheral blood stem cell transplantations after cryopreservationin a-80 °C mechanical freezer and preserved less than 6 months [J].Transfusion,2013,53(3):570-578.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部